Gracell Biotechnologies Surges In Pre-market After $1.2 Bln Acquisition Deal By AstraZeneca

Shares of Gracell Biotechnologies Inc. (GRCL) were trading up over 60 percent after the company signed an agreement to be acquired by AstraZeneca PLC (AZN.L, AZN) for up to $1.2 billion in cash.

from RTT - Before the Bell https://ift.tt/HVc0PWw
via IFTTT